Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Down 5.45%

Collegium Pharmaceutical reported a larger-than-expected loss per share, which contributed to a 5.45% decline in its stock price. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. Overall, the market's negative reaction reflects uncertainty following the earnings report.